# Lung Cancer Mutation Consortium Protocol

> **NCT01014286** · — · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 1100 (actual)

## Conditions studied

- Adenocarcinoma of Lung, Stage IV

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01014286
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09-16
- **Primary completion:** 2016-09-01
- **Final completion:** 2019-01-12
- **Target enrollment:** 1100 (ACTUAL)
- **Last updated:** 2025-01-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01014286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01014286, "Lung Cancer Mutation Consortium Protocol". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01014286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*